HomeINMB • NASDAQ
Follow
INmune Bio Inc
Previous close
$11.63
Day range
$11.28 - $12.05
Year range
$5.87 - $14.74
Market cap
211.75M USD
Avg Volume
72.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 43.00K | -56.12% |
Operating expense | 8.57M | 13.66% |
Net income | -8.56M | -10.85% |
Net profit margin | -19.91K | -152.63% |
Earnings per share | -0.48 | -11.63% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 41.81M | -27.16% |
Total assets | 62.70M | -25.18% |
Total liabilities | 17.97M | -10.59% |
Total equity | 44.73M | — |
Shares outstanding | 18.02M | — |
Price to book | 4.77 | — |
Return on assets | -32.20% | — |
Return on capital | -34.47% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -8.56M | -10.85% |
Cash from operations | -4.26M | -26.64% |
Cash from investing | — | — |
Cash from financing | -1.72M | — |
Net change in cash | -6.01M | -57.88% |
Free cash flow | -1.46M | -77.31% |
About
Founded
2015
Headquarters
Website
Employees
10